GYRE
Gyre Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.84 / 10
Netural
Fund flow momentum is positive (score 7.68/10), with small-cap and block trades leaning in. However, medium and large flows are negative, hinting at selective participation. Analyst coverage is minimal but uniformly bullish (Strong Buy), yet its predictive power is limited by a zero historical win rate.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-10-10
InstitutionJefferies
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of GYRE?
- GYRE holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.84/10 (Netural).
